Novartis Gets Zometa Jaw Injury Suit Thrown Out In Calif.

By Daniel Wilson (August 20, 2014, 6:50 PM EDT) -- A California federal judge on Tuesday dismissed for the second time a suit accusing Novartis Pharmaceuticals Corp.'s bone drug Zometa of causing jaw injuries, ruling the plaintiff could not use Maryland law to skirt a California statute of limitations on the case.

A Maryland federal court had adequately ruled that California law and its relevant two-year statute of limitations applied, not Maryland's three-year statute of limitations, when it transferred plaintiff Michel Hendrix's case to California, meaning Hendrix's case must be dismissed as time-barred — the same as his original California suit — U.S. District Judge Michael W. Fitzgerald ruled.

"Summary judgment...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!